Clinical Trial Update: Clevidipine for Vasoreactivity Evaluation of the Pulmonary Arterial Bed [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating clevidipine for vasoreactivity in the pulmonary arterial bed has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• clevidipine (clevidipine)

Snippet

Sponsor: North Texas Veterans Healthcare System | Conditions: Hypertension, Pulmonary | Phase 4 | Status: COMPLETED